L
Título: Conservative Treatment of Invasive Bladder Cancer
Autores: Souhami, Luis; McGill University
Rene, Nicholas
Cury, Fabio Biagini
Fecha: 2009-07-23
Publicador: Multimed Inc.
Fuente: Ver documento
Tipo: info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

Tema: Cancer, Oncology, Radiation Oncology
Descripción: The concept of organ preserving therapies is a trend in modern oncology and now several tumor types are treated in this fashion. The use of trimodality therapy consisting of a as thorough a transurethral resection of the bladder tumor as is judged safely followed by concomitant chemo-radiation therapy is emerging as an attractive alternative for bladder preservation in selected patients with muscle-invasive bladder cancer. Long-term data from multiple institutional and cooperative group studies have shown that this approach is safe, effective and provides patients with the opportunity of preserving an intact and functional bladder with survival rates similar to modern radical cystectomy rates. Key words: bladder cancer; conservative treatment; radiation therapy; chemotherapy; radio-chemotherapy; trimodality therapy; bladder preservation.
Idioma: Inglés
Artículos similares:
Massage Therapy for Cancer Patients: A Reciprocal Relationship Between Body and Mind por Sagar, Stephen,Dryden, Trish; Centre for Applied Research, Centennial College,Wong, Raimond K; McMaster University, Departments of Medicine and Oncology
Cord stem-cell transplantation in Ontario: do we need a public bank? por Gassas, A.; the Hospital for Sick Children, Toronto
Assessment and management of febrile neutropenia in emergency departments within a regional health authority—a benchmark analysis por Szwajcer, D.; University of Manitoba,Czaykowski, P.; University of Manitoba,Turner, D.; CancerCare Manitoba
Integrating Science and Human Values for Cancer Patient Care por Sutcliffe, Simon B.; BC Cancer Agency
Liver transplantation for symptomatic liver metastases of neuroendocrine tumours por Chan, G.; Hôpital Maisonneuve-Rosemont Université de Montréal,Kocha, W.,Reid, R.,Taqi, A.,Wall, W.,Quan, D.
What is the optimal management of dysphagia in metastatic esophageal cancer? por Cavallin, F.; Veneto Institute of Oncology,Scarpa, M.; Veneto Institute of Oncology,Cagol, M.; Veneto Institute of Oncology,Alfieri, R.; Veneto Institute of Oncology,Castoro, C.; Veneto Institute of Oncology
10 
Responses by breast and prostate cancer patients to out-of-pocket costs in Newfoundland and Labrador por Housser, E.; Newfoundland and Labrador Centre for Health Information,Mathews, M.; Memorial University,LeMessurier, J.; Memorial University,Young, S.; Memorial University,Hawboldt, J.; Memorial University,West, R.; Memorial University